Axicabtagene ciloleucel
Gilead
['dlbcl', 'lymsm', 'cml']
dlbcl cd19 car t contrasts european rwe with us rwe - in part differences in efficacy may relate to manufacturing/transport delays #17icml #lymsm #tcellrx 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem